Find clinical documents

or

Document type:
RAG rating:question mark
Place:
Output type:
Medicine / Guideline Indication RAG rating Document type Place
Alirocumab Primary hypercholesterolaemia and mixed dyslipidaemia Red NICE technology appraisal Hertfordshire and West Essex ICB
Aliskiren Hypertension Double Red Prescribing guideline Hertfordshire and West Essex ICB
Alteplase Acute ischaemic stroke Red NICE technology appraisal Hertfordshire and West Essex ICB
Ambrisentan Pulmonary arterial hypertension (NHSE) Red Decision document Hertfordshire and West Essex ICB
Anagrelide Reduction of elevated platelet counts Red n/a Hertfordshire and West Essex ICB
Andexanet alfa Reversal of anticoagulation Red NICE technology appraisal Hertfordshire and West Essex ICB
Apixaban (generic 1st line) Atrial fibrillation Green n/a Hertfordshire and West Essex ICB
Apixaban (generic 1st line) Treatment of deep vein thrombosis (DVT) or pulmonary embolism (PE) and prevention of recurrent DVT and PE Amber initiation n/a Hertfordshire and West Essex ICB
Apixaban (generic 1st line) VTE prophylaxis following hip and knee surgery Red n/a Hertfordshire and West Essex ICB
Atrial Fibrillation (AF) n/a Clinical pathways Hertfordshire and West Essex ICB
Bempedoic acid Primary hypercholesterolaemia or mixed dyslipidaemia Green NICE technology appraisal Hertfordshire and West Essex ICB
Bosentan Digital ulcers and pulmonary arterial hypertension (NHSE) Red Decision document Hertfordshire and West Essex ICB
Cangrelor Reduction of atherothrombotic events in PCI Double Red NICE technology appraisal Hertfordshire and West Essex ICB
Cilostazol Intermittent claudication in people with peripheral arterial disease Double Red NICE technology appraisal Hertfordshire and West Essex ICB
Ciprofibrate Hypercholesterolaemia Double Red Decision document Hertfordshire and West Essex ICB
Colesevelam Bile acid sequestrants for prevention of CVD Double Red NICE technology appraisal Hertfordshire and West Essex ICB
Colestyramine Bile acid sequestrants for prevention of CVD Double Red NICE technology appraisal Hertfordshire and West Essex ICB
Dalteparin Anticoagulation Red Decision document Hertfordshire and West Essex ICB
Dapagliflozin Heart failure - chronic with preserved or mildly reduced ejection fraction Amber initiation Prescribing guideline Hertfordshire and West Essex ICB
Diagnosing Asymptomatic Heart Murmur n/a Clinical pathways Hertfordshire and West Essex ICB
DOACs Anticoagulation - Atrial fibrillation (AF) guidance Green Prescribing guideline Hertfordshire and West Essex ICB
DOACs Anticoagulation - interactions Green Prescribing guideline Hertfordshire and West Essex ICB
DOACs Anticoagulation - counselling checklist Green Prescribing guideline Hertfordshire and West Essex ICB
Doxazosin (prolonged release) Hypertension, benign prostatic hyperplasia (BPH) Double Red Prescribing guideline Hertfordshire and West Essex ICB
Empagliflozin Heart failure - chronic with preserved or mildly reduced ejection fraction Amber initiation Prescribing guideline Hertfordshire and West Essex ICB
Enoxaparin Anticoagulation Red Decision document Hertfordshire and West Essex ICB
Evolocumab Primary hypercholesterolaemia and mixed dyslipidaemia Red NICE technology appraisal Hertfordshire and West Essex ICB
Exercise Protocol for the Management of CHD (Exercise for Cardiac Conditions) n/a Clinical pathways East and North Hertfordshire
Gemfibrozil Hypercholesterolaemia Double Red Decision document Hertfordshire and West Essex ICB
Heart Failure Suspected n/a Clinical pathways Hertfordshire and West Essex ICB
Hypertension in Adults - Diagnosis and Initial Management n/a Clinical pathways Hertfordshire and West Essex ICB
Icosapent ethyl Hypertriglyceridemia Red Decision document Hertfordshire and West Essex ICB
Inclisiran Primary hypercholesterolaemia and mixed dyslipidaemia Amber initiation NICE technology appraisal Hertfordshire and West Essex ICB
Inclisiran Primary hypercholesterolaemia and mixed dyslipidaemia Amber initiation Prescribing support document Hertfordshire and West Essex ICB
Inositol nicotinate Intermittent claudication in people with peripheral arterial disease Double Red NICE technology appraisal Hertfordshire and West Essex ICB
Ivabradine stable angina and chronic heart failure Amber initiation Prescribing support document Hertfordshire and West Essex ICB
Left Ventricular Systolic Dysfunction (LVSD) Management n/a Clinical pathways Hertfordshire and West Essex ICB
Lipid management patient decision aid statin therapy n/a Patient information Hertfordshire and West Essex ICB
Lipid management pathway Statin intolerance n/a Prescribing pathway Hertfordshire and West Essex ICB
Lipid management pathway Primary & secondary prevention n/a Prescribing pathway Hertfordshire and West Essex ICB
Lomitapide Homozygous familial hypercholesterolaemia (NHSE) Red Decision document Hertfordshire and West Essex ICB
Low molecular weight heparin (LMWH) Anticoagulation Red Decision document Hertfordshire and West Essex ICB
Macitentan Pulmonary arterial hypertension (NHSE) Red Decision document Hertfordshire and West Essex ICB
Metolazone Oedema n/a Patient information Hertfordshire and West Essex ICB
Metolazone Oedema Red Decision document Hertfordshire and West Essex ICB
Mexiletine Life threatening ventricular arrhythmias (unlicensed - acute provider only) Red Decision document Hertfordshire and West Essex ICB
Naftidrofuryl Oxalate Intermittent claudication in people with peripheral arterial disease Green NICE technology appraisal Hertfordshire and West Essex ICB
Nicotinic acid Prevention of CVD Double Red NICE technology appraisal Hertfordshire and West Essex ICB
Omega 3 fatty acid Primary or secondary prevention of CVD, sleep problems, multiple sclerosis (MS), familial hypercholesterolemia Double Red Prescribing guideline Hertfordshire and West Essex ICB
Omega 3 fatty acid Hypertriglyceridaemia - severe Amber initiation Decision document Hertfordshire and West Essex ICB
Palpitations n/a Clinical pathways East and North Hertfordshire
Pentoxifylline Intermittent claudication in people with peripheral arterial disease Double Red NICE technology appraisal Hertfordshire and West Essex ICB
Perindopril arginine Heart failure, hypertension and prophylaxis of CV events Double Red Prescribing guideline Hertfordshire and West Essex ICB
Prasugrel Percutaneous coronary intervention (PCI) for treating acute coronary syndromes (ACS) Amber initiation NICE technology appraisal Hertfordshire and West Essex ICB
Rivaroxaban Prevention of atherothrombotic events in patients after an acute coronary syndrome Amber initiation NICE technology appraisal Hertfordshire and West Essex ICB
Rivaroxaban Preventing atherothrombotic events in people with coronary or peripheral artery disease Red NICE technology appraisal Hertfordshire and West Essex ICB
Sacubitril valsartan Heart failure Amber initiation Prescribing support document Hertfordshire and West Essex ICB
Sildenafil (20mg tablets) Pulmonary arterial hypertension (NHSE) Red Decision document Hertfordshire and West Essex ICB
Statin patient decision aid - NICE Hypercholesterolaemia n/a Patient information Hertfordshire and West Essex ICB
Ticagrelor Preventing atherothrombotic events after myocardial infarction Amber initiation NICE technology appraisal Hertfordshire and West Essex ICB
Varicose Veins Management n/a Clinical pathways Hertfordshire and West Essex ICB
Vericiguat Heart failure - chronic with reduced ejection fraction Double Red NICE technology appraisal Hertfordshire and West Essex ICB
Vernakalant Atrial fibrillation Double Red NICE technology appraisal Hertfordshire and West Essex ICB